Skip to main content
logo
Atara Biotherapeutics logo
Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
9.48
+0.25 (2.71%)
Oct 9, 2026, 4:00 PM EDT - Market closed

Atara Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
9513077523111,393
Market Cap Growth
-14.50%70.14%46.68%-83.20%-77.67%-14.29%
Enterprise Value
9513459121221,061
Last Close Price
9.4818.0913.3112.8282.00394.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-3.99----
Forward PE
31.8719.660.30---
PS Ratio
15.361.080.606.104.8968.51
PB Ratio
--3.39-0.79-0.532.464.98
P/TBV Ratio
----2.464.98

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
15.361.110.461.361.9352.15
EV/EBITDA Ratio
-2.59----
EV/EBIT Ratio
-2.70----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.27-0.27-0.45-0.580.570.10
Debt / EBITDA Ratio
-0.18----
Net Debt / Equity Ratio
0-0.05-0.01-0.06-1.35-1.23
Net Debt / EBITDA Ratio
0.000.04-0.02-0.020.641.03
Net Debt / FCF Ratio
0-0.04-0.02-0.030.621.48
Asset Turnover
0.211.870.940.030.150.04
Inventory Turnover
--15.2540.39--
Quick Ratio
1.490.650.330.603.603.53
Current Ratio
1.980.820.480.723.743.64
Return on Equity (ROE)
----2014.86%-112.39%-91.69%
Return on Assets (ROA)
-24.14%47.81%-35.66%-62.11%-40.63%-40.29%
Return on Capital Employed (ROCE)
-78.90%931.10%307.50%-1156.80%-92.30%-94.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-17.54%25.06%-111.40%-528.31%-73.36%-24.41%
FCF Yield
-23.01%-39.05%-89.96%-371.56%-88.25%-16.59%
Buyback Yield / Dilution
-36.26%-69.84%-76.77%-3.83%-8.88%-26.63%
SEC Filings: 10-K · 10-Q